why choose us

300×250 Ad Slot

Research Article: An exploratory clinical study of ?-glucan combined with camrelizumab and SOX chemotherapy as first-line treatment for advanced gastric adenocarcinoma

Date Published: 2024-08-26

Abstract:
Background: ?-glucan has been reported to be a potential natural immune modulator for tumor growth inhibition. We aimed to evaluate the efficacy and safety of ?-glucan plus immunotherapy and chemotherapy in the first-line treatment of advanced gastric adenocarcinoma.

No summary available.

300×250 Ad Slot